Back to Trades
Curran Terrie
DirectorCIK 0001690298
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Curran Terrie, Director, has filed 1 SEC report (2026), all concentrated in Arcutis Biotherapeutics, Inc. (ARQT), totaling $353.8K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Jun 9 | ARQT Arcutis Biotherapeutics, Inc. | Curran Terrie | Director | Grant | $353.8K |
1 filing